AG Paxton Applauds $1.6 Billion Global Settlement with Opioid Manufacturer
Attorney General Ken Paxton today announced a global settlement framework agreement between state attorneys general, local subdivisions, and Mallinckrodt (MNK), its subsidiaries, and certain other affiliates.
AG Paxton: All U.S. Attorneys General Call on Congress to Pass Bipartisan FIGHT Fentanyl Act
Attorney General Ken Paxton today joined all 56 attorneys general in calling for Congress to pass the bipartisan Federal Initiative to Guarantee Health by Targeting (FIGHT) Fentanyl Act.
Attorney General Ken Paxton Issues Statement on Chapter 11 Bankruptcy Filing of Purdue Pharma
Attorney General Paxton released the following statement in response to the Chapter 11 bankruptcy filing of Purdue Pharma and all affiliated U.S. companies in the United States Bankruptcy Court for the Southern District of New York.
AG Paxton Announces Medicaid Fraud Suit Against Opioid Manufacturer Johnson & Johnson
Texas Attorney General Ken Paxton announced that his office filed a civil Medicaid fraud lawsuit against pharmaceutical manufacturer Johnson & Johnson, and its subsidiary Janssen Pharmaceuticals, Inc., for misrepresentations made to the Texas Medicaid program about their dangerous opioid drug, Duragesic.
AG Paxton Joins U.S. AG Sessions at Press Conference Announcing DOJ’s New Steps to Combat the Nation’s Opioid Epidemic
“I shouldn't have to tell another story like this one, nor should anyone else,” Attorney General Paxton said. “The opioid crisis demands the attention of federal, state, local and private sector leaders. My office will continue to do everything it can to protect Texans from the opioid crisis.”